The global biomedical optical coherence tomography market is anticipated to grow significantly over the forecast period. Biomedical optical coherence tomography is a non-invasive medical procedure that utilizes light waves to perform high-resolution cross-sectional imaging of the internal structure. Biomedical OCT is an emerging technology and holds immense future growth opportunities. Some of the advantages of biomedical optical coherence tomography compared to non-optical imaging modalities include the former offers high depth and transversal resolution, is based on function dependent image contrast, and is non-invasive in nature. Biomedical optical coherence tomography is used to image various aspects of biological tissues namely structural information, polarization sensitivity, and blood flow.
The growing demand for non-invasive medical procedures and the global prevalence of ophthalmic diseases are two of the most significant growth drivers of the global biomedical optical coherence tomography market. Some of the other drivers of this market include the growing base of the global geriatric population, rising incidences of skin and neurology based disorders and demand for non-radiation imaging modalities, and increasing patient awareness levels.
The future of this market will be fuelled by factors such as the presence of high unmet medical needs and constantly improving healthcare infrastructure in emerging Asian and Latin American economies. Moreover, rising market penetration of relatively niche technologies such as the high-resolution optical coherence tomography in the fields of dermatology and gastroenterology will serve this market as a future growth opportunity.
North America is expected to dominate the overall market throughout the forecast period. The presence of relatively higher usage rates of advanced imaging modalities and high healthcare expenditures in the U.S. are some of the attributes accounting for the aforementioned inference. However, the availability of abundant growth opportunities in emerging Asian economies will help the Asia-Pacific grow at the fastest rate during the forecast period.
This research study encompasses a competitive landscape of the biomedical optical coherence tomography market. Revenue analysis, product benchmarking, and strategic developments of key market players such as Agfa HealthCare, Michelson Diagnostics, Carl Zeiss, Heliotis AG, and others are also provided in this report.
This report, by Grand View Research, takes a closer look at the biomedical optical coherence tomography industry, providing a holistic perspective on market dynamics, trends, supply, and demand. The report deep-dives into the market and segments it on multiple levels and providing key insights on a macro as well as micro-level. The study aims at providing granular information, regarding estimates and forecasts for key product segments including time-domain and polarization-sensitive OCT, full-field and optical delay OCT and fourier domain and time encoded Biomedical OCT Market. This report also encompasses market estimates and forecasts of key application segments namely ophthalmology, dermatology, cancer diagnosis, gastroenterology, dentistry, and intra surgery for tumor margining. The report also provides the same level of information for key regional markets.
This research report analyzes various factors which have been driving and inhibiting the global biomedical optical coherence tomography market in the past. In addition, the report analyzes the impact of each driver and restraint on the market growth, which forms the base for the market forecast. The report also showcases the opportunities available in the market which may act as future drivers for the market.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent..."
Amongst the majorly used Covid-19 screening options, imaging is preferred by most healthcare professionals as it provides a primary diagnosis in a short time. All the imaging modalities including nuclear imaging have been used exhaustively to study Covid-19 and its effect on different patients in each demography. These are used in theories such as comparison of the vulnerability of pediatric and geriatric patients, and treatment response for several drug combinations. The rising requirement for advanced lung imaging solutions is expected to boost the development studies for lung phantoms. A detailed study on lung deterioration in Covid-19 patients is expected to provide advanced measures for early detection of the disease. The report will account for Covid19 as a key market contributor.